Athira Pharma (ATHA) Expected to Announce Earnings on Thursday

Athira Pharma (NASDAQ:ATHA) is anticipated to post its quarterly earnings results on Thursday, February 20th. Analysts expect Athira Pharma to post earnings of ($0.45) per share for the quarter.

Athira Pharma Price Performance

ATHA stock opened at $0.45 on Thursday. The company has a fifty day moving average price of $0.55 and a 200 day moving average price of $1.03. Athira Pharma has a 12 month low of $0.41 and a 12 month high of $4.30. The company has a market cap of $17.36 million, a price-to-earnings ratio of -0.16 and a beta of 2.97.

About Athira Pharma

Athira Pharma, Inc, a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. Its lead product candidate is Fosgonimeton (ATH-1017), a small molecule designed to modulate the neurotrophic hepatocyte growth factor (HGF) system and its receptor, MET, for a healthy nervous system that is in LIFT-AD Phase 2/3 and ACT-AD Phase 2 clinical trials for the treatment of Alzheimer's disease, as well as is in Phase 2 clinical trials to treat Parkinson's disease dementia and Dementia with Lewy bodies.